M

Morad Elmi

About

Detail

Co-Founder & Chief Strategy Officer
Washington, District of Columbia, United States

Timeline

work
Job
folder
Project

Résumé

Jobs verified_user 0% verified
  • Scene Health
    Co-Founder & Chief Strategy Officer
    Scene Health
    Dec 2013 - Current (12 years 7 months)
    Scene Health (formerly emocha) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. We partner with pharmaceutical companies, health plans, and public health departments to support patients at every dose through our Digital Medication Adherence Programs. Visit us at www.scene.health to learn more.
  • The Johns Hopkins University Carey Business School
    Marketing Associate
    The Johns Hopkins University Carey Business School
    Sep 2012 - Dec 2013 (1 year 4 months)
  • Opower
    Summer Associate
    Opower
    Jun 2012 - Aug 2012 (3 months)
  • US House of Representatives
    Legislative Assistant
    US House of Representatives
    May 2009 - Aug 2011 (2 years 4 months)
    • Managed a legislative portfolio that included international affairs and appropriations, trade, labor, immigration, telecommunications, civil rights, and judiciary issues, as well as the Congressional-Executive Commission on China and the Ukrainian Caucus • Recognized as a “Hill Staffer to Watch” by The Cable • Selected as a "Partnership for a Secure America" fellow
  • US House of Representatives
    Legislative Correspondent
    US House of Representatives
    Aug 2007 - May 2009 (1 year 10 months)
  • US House of Representatives
    Congressional Intern
    US House of Representatives
    May 2007 - Aug 2007 (4 months)
Education verified_user 0% verified
  • Miami University
    BA, Political Science, Pre-Medicine
    Miami University
  • The Johns Hopkins University Carey Business School
    MBA, Healthcare, Marketing
    The Johns Hopkins University Carey Business School
Projects (professional or personal) verified_user 0% verified
  • J
    Johns Hopkins Wilmer Eye Institute Discovery to Market Project
    Sep 2012 - Apr 2013 (8 months)
    • Provided IP strategy recommendation to doctors at Johns Hopkins Wilmer Eye Institute on nano-particle therapeutics for wet Age-related Macular Degeneration(AMD) • Corrected existing market sizing error through primary research, conducted competitive analysis and pipeline research, analyze key competitors and stakeholders • Researched on FDA approval process, legal and regulatory factors, and other non-market forces • Established four business model options and advised clients on implementation plans
This is a community-created genome.